Posted: 10 Aug 15
Edited: 8 Aug 18
Guidelines Cardiovascular
The guidance covers the use of anti-platelets in the manangement of cardiovascular and cerebrovascualr disease including secondary prevention; acute coronary syndrome;stroke and ischaemic attacks and peripheral arterial disease. The use of dual antiplatelet treatment for ACS is in line with the West of Scotland guidance as followed by the Jubilee.